Home | Business News | Browse by Publication | P | Pharma Marketletter

US FDA accepts NDAs from Genentech, Eisai, GSK and S-P.

Publication: Pharma Marketletter
Publication Date: 20-FEB-06
Format: Online
Delivery: Immediate Online Access
Full Article Title: US FDA accepts NDAs from Genentech, Eisai, GSK and S-P.(Herceptin )(Brief Article)

Article Excerpt
US biotechnology major Genentech has completed the...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Merck KGaA completes enrollment in Ph III Erbitux program.(cancer drug..., February 20, 2006
KV acquires US marketing rights to a $2B Gedeon Richter generics portf..., February 20, 2006
Ligand earns $2M eltrombopag milestone from GSK.(Ligand Pharmaceutical..., February 20, 2006
Biolyse Pharma seeks approval for generic Tamiflu.(influenza drug)(Bri..., February 20, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.